Neogen Stock Operating Margin

NEOG Stock

USD 4.66 0.01 0.22%

Fundamental analysis of Neogen allows traders to better anticipate movements in Neogen's stock price by examining its financial health and performance throughout various phases of its business cycle.

		Last Reported	Projected for Next Year
	Operating Profit Margin	(1.19)	(1.13)

Build AI portfolio with Neogen Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Neogen Company Operating Margin Analysis

Neogen's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

Operating Income

Revenue

100

More About Operating Margin | All Equity Analysis

Current Neogen Operating Margin

(0.06) %

Most of Neogen's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Neogen Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Neogen is extremely important. It helps to project a fair market value of Neogen Stock properly, considering its historical fundamentals such as Operating Margin. Since Neogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neogen's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Short Term Investments	Common Stock	Long Term Debt	Good Will	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Net Invested Capital	Net Working Capital	Capital Stock	Short Long Term Debt
Total Assets		0.99	0.85	-0.15	0.93	0.98	0.69	0.81	0.99	0.98	-0.26	-0.41	0.67	0.89	0.94	0.62	0.96	-0.18	0.96	-0.74	-0.83	0.96	0.5	0.96	0.49
Total Stockholder Equity	0.99		0.82	-0.04	0.93	0.95	0.73	0.75	0.96	0.96	-0.18	-0.43	0.7	0.91	0.92	0.61	0.93	-0.12	0.92	-0.71	-0.86	0.96	0.54	0.95	0.4
Net Debt	0.85	0.82		-0.33	0.76	0.88	0.52	0.81	0.87	0.87	-0.32	-0.33	0.51	0.71	0.83	0.78	0.88	-0.25	0.87	-0.96	-0.69	0.81	0.38	0.86	0.56
Retained Earnings	-0.15	-0.04	-0.33		-0.09	-0.35	0.15	-0.62	-0.31	-0.26	0.61	-0.05	0.09	0.11	-0.29	-0.17	-0.4	0.54	-0.42	0.32	-0.1	-0.07	0.24	-0.16	-0.82
Net Receivables	0.93	0.93	0.76	-0.09		0.89	0.88	0.76	0.89	0.96	-0.01	-0.41	0.78	0.74	0.97	0.52	0.91	-0.23	0.89	-0.61	-0.93	0.86	0.66	0.89	0.52
Total Liab	0.98	0.95	0.88	-0.35	0.89		0.61	0.89	1.0	0.97	-0.38	-0.38	0.6	0.83	0.94	0.62	0.99	-0.28	0.99	-0.77	-0.76	0.92	0.41	0.94	0.62
Total Current Assets	0.69	0.73	0.52	0.15	0.88	0.61		0.47	0.61	0.76	0.46	-0.56	0.91	0.52	0.82	0.43	0.67	-0.08	0.62	-0.37	-0.95	0.62	0.92	0.7	0.36
Short Term Debt	0.81	0.75	0.81	-0.62	0.76	0.89	0.47		0.87	0.87	-0.49	-0.29	0.48	0.51	0.85	0.6	0.91	-0.47	0.92	-0.73	-0.58	0.77	0.29	0.79	0.79
Intangible Assets	0.99	0.96	0.87	-0.31	0.89	1.0	0.61	0.87		0.97	-0.37	-0.37	0.6	0.86	0.94	0.62	0.98	-0.26	0.99	-0.77	-0.76	0.93	0.41	0.94	0.59
Accounts Payable	0.98	0.96	0.87	-0.26	0.96	0.97	0.76	0.87	0.97		-0.2	-0.43	0.72	0.8	0.99	0.63	0.99	-0.26	0.97	-0.75	-0.87	0.91	0.56	0.94	0.61
Short Term Investments	-0.26	-0.18	-0.32	0.61	-0.01	-0.38	0.46	-0.49	-0.37	-0.2		-0.38	0.45	-0.22	-0.11	-0.1	-0.31	0.32	-0.37	0.35	-0.29	-0.27	0.66	-0.19	-0.32
Common Stock	-0.41	-0.43	-0.33	-0.05	-0.41	-0.38	-0.56	-0.29	-0.37	-0.43	-0.38		-0.7	-0.32	-0.45	-0.37	-0.41	-0.21	-0.39	0.36	0.59	-0.41	-0.73	-0.45	-0.22
Long Term Debt	0.67	0.7	0.51	0.09	0.78	0.6	0.91	0.48	0.6	0.72	0.45	-0.7		0.51	0.76	0.48	0.65	-0.01	0.62	-0.4	-0.9	0.62	0.93	0.68	0.36
Good Will	0.89	0.91	0.71	0.11	0.74	0.83	0.52	0.51	0.86	0.8	-0.22	-0.32	0.51		0.73	0.53	0.77	0.0	0.78	-0.64	-0.69	0.86	0.36	0.84	0.17
Property Plant Equipment	0.94	0.92	0.83	-0.29	0.97	0.94	0.82	0.85	0.94	0.99	-0.11	-0.45	0.76	0.73		0.6	0.97	-0.29	0.95	-0.69	-0.89	0.86	0.63	0.92	0.66
Current Deferred Revenue	0.62	0.61	0.78	-0.17	0.52	0.62	0.43	0.6	0.62	0.63	-0.1	-0.37	0.48	0.53	0.6		0.62	-0.2	0.62	-0.76	-0.59	0.65	0.44	0.76	0.41
Net Tangible Assets	0.96	0.93	0.88	-0.4	0.91	0.99	0.67	0.91	0.98	0.99	-0.31	-0.41	0.65	0.77	0.97	0.62		-0.31	1.0	-0.77	-0.8	0.89	0.47	0.93	0.69
Long Term Debt Total	-0.18	-0.12	-0.25	0.54	-0.23	-0.28	-0.08	-0.47	-0.26	-0.26	0.32	-0.21	-0.01	0.0	-0.29	-0.2	-0.31		-0.32	0.21	0.02	-0.04	0.05	-0.11	-0.43
Capital Surpluse	0.96	0.92	0.87	-0.42	0.89	0.99	0.62	0.92	0.99	0.97	-0.37	-0.39	0.62	0.78	0.95	0.62	1.0	-0.32		-0.76	-0.76	0.89	0.43	0.92	0.69
Deferred Long Term Liab	-0.74	-0.71	-0.96	0.32	-0.61	-0.77	-0.37	-0.73	-0.77	-0.75	0.35	0.36	-0.4	-0.64	-0.69	-0.76	-0.77	0.21	-0.76		0.54	-0.72	-0.27	-0.75	-0.48
Accumulated Depreciation	-0.83	-0.86	-0.69	-0.1	-0.93	-0.76	-0.95	-0.58	-0.76	-0.87	-0.29	0.59	-0.9	-0.69	-0.89	-0.59	-0.8	0.02	-0.76	0.54		-0.79	-0.86	-0.86	-0.4
Net Invested Capital	0.96	0.96	0.81	-0.07	0.86	0.92	0.62	0.77	0.93	0.91	-0.27	-0.41	0.62	0.86	0.86	0.65	0.89	-0.04	0.89	-0.72	-0.79		0.43	0.96	0.44
Net Working Capital	0.5	0.54	0.38	0.24	0.66	0.41	0.92	0.29	0.41	0.56	0.66	-0.73	0.93	0.36	0.63	0.44	0.47	0.05	0.43	-0.27	-0.86	0.43		0.53	0.2
Capital Stock	0.96	0.95	0.86	-0.16	0.89	0.94	0.7	0.79	0.94	0.94	-0.19	-0.45	0.68	0.84	0.92	0.76	0.93	-0.11	0.92	-0.75	-0.86	0.96	0.53		0.55
Short Long Term Debt	0.49	0.4	0.56	-0.82	0.52	0.62	0.36	0.79	0.59	0.61	-0.32	-0.22	0.36	0.17	0.66	0.41	0.69	-0.43	0.69	-0.48	-0.4	0.44	0.2	0.55

Click cells to compare fundamentals

A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Competition

Predict Neogen

Operating Profit Margin Over Time

Neogen Pretax Profit Margin

Pretax Profit Margin

(1.16)

At this time, Neogen's Pretax Profit Margin is most likely to slightly decrease in the upcoming years.

Based on the recorded statements, Neogen has an Operating Margin of -0.0588%. This is 99.83% lower than that of the Health Care Equipment & Supplies sector and 99.91% lower than that of the Health Care industry. The operating margin for all United States stocks is 98.93% lower than that of the firm.

Neogen Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neogen's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics of similar companies.

Neogen is currently under evaluation in operating margin category among its peers.

Neogen ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Neogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Neogen's managers, analysts, and investors.

Environmental

Governance

Social

Neogen Fundamentals

	Return On Equity	-0.42
	Return On Asset	-3.0E-4
	Profit Margin	(1.22) %
	Operating Margin	(0.06) %
	Current Valuation	1.78 B
	Shares Outstanding	217.2 M
	Shares Owned By Insiders	0.38 %
	Shares Owned By Institutions	99.62 %
	Number Of Shares Shorted	18.31 M
	Price To Earning	13.36 X
	Price To Book	0.49 X
	Price To Sales	1.13 X
	Revenue	894.66 M
	Gross Profit	421.38 M
	EBITDA	(1.06 B)
	Net Income	(1.09 B)
	Cash And Equivalents	347.71 M
	Cash Per Share	3.22 X
	Total Debt	19.3 M
	Debt To Equity	0 %
	Current Ratio	9.07 X
	Book Value Per Share	9.54 X
	Cash Flow From Operations	58.24 M
	Short Ratio	2.78 X
	Earnings Per Share	(5.03) X
	Price To Earnings To Growth	0.66 X
	Target Price	6.5
	Number Of Employees	2.92 K
	Beta	1.77
	Market Capitalization	1.01 B
	Total Asset	3.44 B
	Retained Earnings	(536.42 M)
	Working Capital	402.93 M
	Current Asset	250 M
	Current Liabilities	28.6 M
	Net Asset	3.44 B

About Neogen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

USOI	Credit Suisse X Links
ULTY	Tidal Trust II
CONY	YieldMax N Option
BCAT	BlackRock Capital Allocation
PDI	Pimco Dynamic Income

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:

How To Invest In Neogen

Details

Is Neogen Stock a good investment?

Details

What is Neogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Neogen Piotroski F Score and Neogen Altman Z Score analysis.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.86)

Earnings Share

(5.03)

Revenue Per Share

4.125

Quarterly Revenue Growth

(0.05)

Return On Assets

(0.0003)

The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Neogen Stock Operating Margin

Neogen Company Operating Margin Analysis

Operating Margin

Operating Income

Revenue

100

Current Neogen Operating Margin

Neogen Operating Margin Driver Correlations

Neogen Pretax Profit Margin

Pretax Profit Margin

(1.16)

Neogen Operating Margin Peer Comparison

Neogen ESG Sustainability

Neogen Fundamentals

About Neogen Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY